MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: The 8-year results of the intergroup trial

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 19-26

  Glick, John H ^a   Young, Mary L ^a   Harrington, David ^a   Schilsky, Richard L ^a   Beck, Thomas ^a   Neiman, Richard ^a   Fisher, Richard I ^a   Peterson, Bruce A ^a   Oken, Martin M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CHLORMETHINE; DACARBAZINE; DOXORUBICIN; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DYSCRASIA; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FEVER; HODGKIN DISEASE; HUMAN; INFECTION; LUNG TOXICITY; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; NAUSEA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0031961809     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.19     Document Type: Article

References (19)

1. DeVita Jr, Serpick AA, Carbone PP: Combination chemotherapy in the treatment of advanced Hodgkin's disease. Ann Intern Med 73:891-895, 1970
2. Longo DL, Young RC, Wesley M, et al: Twenty years of MOPP chemotherapy for Hodgkin's disease. J Clin Oncol 4:1295-1306, 1986
3. Bonadonna G: Chemotherapy strategies to improve the control of Hodgkin's disease. Rosenthal Award Lecture. Cancer Res 42:4309-4320, 1982
4. Bonadonna G, Valagussa P, Santoro A: Alternating non-cross resistant combination chemotherapy with ABVD or MOPP in stage IV Hodgkin's disease: A report of eight year results. Ann Intern Med 104:739-746, 1986
5. Canellos G, Anderson JR, Propert KJ, et al: Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med 327:1478-1484, 1992
6. Glick JH, Tsiatis A, Chen A, et al: Improved survival with MOPP-ABVD compared to BCVPP ± radiotherapy for advanced Hodgkin's disease: 6-year ECOG results. Blood 76:351, 1990
7. Klimo P, Connors JM: MOPP/ABV hybrid program: Combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease. J Clin Oncol 3:1174-1182, 1985
8. Goldie JH, Coldman AJ, Gudauskas GA: Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep 66:439, 1982
9. Glick JH, Barnes JM, Bakemeier RF, et al: Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology Group. Cancer Treat Rep 66:855-870, 1982
10. Glick JH, Tsiatis A: MOPP/ABVD chemotherapy for advanced Hodgkin's disease. Ann Intern Med 104:876-878, 1986
11. Lister TA, Crowther D, Sutcliffe S, et al: Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7:1630-1636, 1989 (Erratum, J Clin Oncol 8:1602, 1990)
12. Wittes RE: Manual of Oncologic Therapeutics. Philadelphia, PA, Lippincott, 1989, pp 627-632
13. Cox DR: Analysis of Binary Data. London, United Kingdom, Methuen, 1970
14. Peto R, Peto J: Asymptotically efficient rank invariant test procedures. J R Stat Soc 135:185-206, 1972
15. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
16. Cox DR: Regression models and life tables. J R Stat Soc B 34:181-220, 1972
17. Viviani S, Bonadonna G, Santoro A, et al: Alternating vs. hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: Ten-year results. J Clin Oncol 14:1421-1430, 1996
18. Connors JH, Klimo P, Adams G, et al: Treatment of advanced Hodgkin's disease with chemotherapy - A comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: A report from the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 15:1638-1645, 1997
19. Duggan D, Petroni J, Johnson J, et al: MOPP/ABV vs. ABVD for advanced Hodgkin's disease: A preliminary report of CALGB 8952 (with SWOG, ECOG. NCIC). Proc Am Soc Clin Oncol 16:12a, 1997 (abstr)